Cholesterol in Relation to COVID-19: Should We Care about It?
Editorial
[키워드] ACE2
activities
acute respiratory syndrome
addition
angiotensin-converting enzyme 2
Anti-inflammatory
Antithrombotic
antiviral activity
appear
Atherosclerosis
Blood
cardiovascular complication
cardiovascular disease
caused
cholesterol
Clinical course
complications of COVID-19
contributing to
coronavirus
Coronavirus infection
COVID-19
critical appraisal
current
CVD
Effects
evidence of
Hepatitis
host cell
hypertension
immunomodulatory
Infection
influenza infection
inhibitors
intubation
lipid-lowering therapy
Lower
Mortality
Patient
pharmacological interventions
plasma membrane
pleiotropic effect
receptor
reduce
reducing
relation
reported
risk
S-protein
SARS-CoV-2
SARS-CoV-2 main protease
severity
shown
statin
statins
therapy
viral clearance
viral entry
viral infection
viral infectivity
virus
[DOI] 10.3390/jcm9061909 PMC 바로가기 [Article Type] Editorial
[DOI] 10.3390/jcm9061909 PMC 바로가기 [Article Type] Editorial